Search research articles
Contact Us
Filters
Showing results (71-80 of 99) with videos related to
Page
of 10
Sort By:
Arthritis and Rheumatism
|
June 11, 1992
Lymphokine-activated killer cell and natural killer cell activities in patients with systemic sclerosis
T V Kantor, T L Whiteside, D Friberg, et al.
Clinical Immunology and Immunopathology
|
December 11, 1992
Cytokine production and serum levels in systemic sclerosis
T V Kantor, D Friberg, T A Medsger, et al.
Journal of Clinical Pharmacology
|
January 1, 1983
Suppression of postoperative pain by preoperative administration of ibuprofen in comparison to placebo, acetaminophen, and acetaminophen plus codeine
R A Dionne, R A Campbell, S A Cooper, et al.
Journal of Clinical Immunology
|
November 1, 1984
Autologous mixed lymphocyte reaction in man: XV. Cellular and molecular basis of deficient autologous mixed lymphocyte response in insulin-dependent diabetes mellitus
K G Chandy, A M Charles, A Kershnar, et al.
The Journal of Rheumatology
|
September 1, 1980
Bleomycin-induced scleroderma
W R Finch, G P Rodnan, R B Buckingham, et al.
Arthritis and Rheumatism
|
February 1, 1985
Soluble mediators from mononuclear cells increase the synthesis of glycosaminoglycan by dermal fibroblast cultures derived from normal subjects and progressive systemic sclerosis patients
T L Whiteside, J G Worrall, R K Prince, et al.
Molecular Therapy. Nucleic Acids
|
October 22, 2024
Optimization of a lentivirus-mediated gene therapy targeting HIV-1 RNA to eliminate HIV-1-infected cells
Amanda B Buckingham, Sophia Ho, Finlay Knops-Mckim, et al.
Diabetes Research (Edinburgh, Scotland)
|
January 1, 1988
Interferon responsiveness of natural killer cells in type I human diabetes
K Negishi, S Gupta, K G Chandy, et al.
Experimental and Clinical Endocrinology
|
August 1, 1987
Natural killer cell and islet killer cell activities in human type 1 diabetes
K Negishi, N Waldeck, G Chandy, et al.
Diabetologia
|
June 1, 1986
Natural killer cell and islet killer cell activities in type 1 (insulin-dependent) diabetes
K Negishi, N Waldeck, G Chandy, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 99) with videos related to
Sort By:
Page
of 10
Arthritis and Rheumatism
|
June 11, 1992
Lymphokine-activated killer cell and natural killer cell activities in patients with systemic sclerosis
T V Kantor, T L Whiteside, D Friberg, et al.
Clinical Immunology and Immunopathology
|
December 11, 1992
Cytokine production and serum levels in systemic sclerosis
T V Kantor, D Friberg, T A Medsger, et al.
Journal of Clinical Pharmacology
|
January 1, 1983
Suppression of postoperative pain by preoperative administration of ibuprofen in comparison to placebo, acetaminophen, and acetaminophen plus codeine
R A Dionne, R A Campbell, S A Cooper, et al.
Journal of Clinical Immunology
|
November 1, 1984
Autologous mixed lymphocyte reaction in man: XV. Cellular and molecular basis of deficient autologous mixed lymphocyte response in insulin-dependent diabetes mellitus
K G Chandy, A M Charles, A Kershnar, et al.
The Journal of Rheumatology
|
September 1, 1980
Bleomycin-induced scleroderma
W R Finch, G P Rodnan, R B Buckingham, et al.
Arthritis and Rheumatism
|
February 1, 1985
Soluble mediators from mononuclear cells increase the synthesis of glycosaminoglycan by dermal fibroblast cultures derived from normal subjects and progressive systemic sclerosis patients
T L Whiteside, J G Worrall, R K Prince, et al.
Molecular Therapy. Nucleic Acids
|
October 22, 2024
Optimization of a lentivirus-mediated gene therapy targeting HIV-1 RNA to eliminate HIV-1-infected cells
Amanda B Buckingham, Sophia Ho, Finlay Knops-Mckim, et al.
Diabetes Research (Edinburgh, Scotland)
|
January 1, 1988
Interferon responsiveness of natural killer cells in type I human diabetes
K Negishi, S Gupta, K G Chandy, et al.
Experimental and Clinical Endocrinology
|
August 1, 1987
Natural killer cell and islet killer cell activities in human type 1 diabetes
K Negishi, N Waldeck, G Chandy, et al.
Diabetologia
|
June 1, 1986
Natural killer cell and islet killer cell activities in type 1 (insulin-dependent) diabetes
K Negishi, N Waldeck, G Chandy, et al.
Page
of 10